A retrospective cohort study on the comparative safety of glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors on the onset of gallbladder disease in type II diabetes

Katie Carlson, Jasmeen Kaur, Charles E. Gaber, Sirimon Reutrakul, Kibum Kim

Open source

DOI
10.1080/03007995.2026.2726017
Published
2026-09-09
Container
Current Medical Research and Opinion
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/03007995.2026.2726017,
  title = {A retrospective cohort study on the comparative safety of glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors on the onset of gallbladder disease in type II diabetes},
  author = {Katie Carlson and Jasmeen Kaur and Charles E. Gaber and Sirimon Reutrakul and Kibum Kim},
  year = {2026},
  journal = {Current Medical Research and Opinion},
  doi = {10.1080/03007995.2026.2726017},
  url = {https://doi.org/10.1080/03007995.2026.2726017}
}

RIS

TY  - JOUR
TI  - A retrospective cohort study on the comparative safety of glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors on the onset of gallbladder disease in type II diabetes
AU  - Katie Carlson
AU  - Jasmeen Kaur
AU  - Charles E. Gaber
AU  - Sirimon Reutrakul
AU  - Kibum Kim
PY  - 2026
JO  - Current Medical Research and Opinion
DO  - 10.1080/03007995.2026.2726017
UR  - https://doi.org/10.1080/03007995.2026.2726017
ER  - 

APA

Carlson, K., Kaur, J., Gaber, C. E., Reutrakul, S., & Kim, K. (2026). A retrospective cohort study on the comparative safety of glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors on the onset of gallbladder disease in type II diabetes. Current Medical Research and Opinion. https://doi.org/10.1080/03007995.2026.2726017

Source records